Skip to main content
. 2019 Mar 28;125(14):2474–2487. doi: 10.1002/cncr.32116

Figure 5.

Figure 5

OS according to subgroups. BMA indicates bone marrow aspirate; CI, confidence interval; InO, inotuzumab ozogamicin; OS, overall survival; Ph–, Philadelphia chromosome–negative; Ph+, Philadelphia chromosome–positive; SoC, standard of care (intensive chemotherapy).